Prot #B7931005: A Phase 2a Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate the Efficacy And Safety Profile of PF-06651600 and PF-06700841 in Subjects With Moderate To Severe Alopecia Areata